XML 64 R53.htm IDEA: XBRL DOCUMENT
v3.23.2

Significant Payors (Revenue by Geographic Location) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022
Net service revenues | $ 259,980 | $ 236,940 | $ 511,579 | $ 463,574
Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member] |  |  |  |
Concentration risk, percentage | 45.70% | 43.80% | 45.40% | 41.60%
Personal Care [Member] |  |  |  |
Net service revenues | $ 198,314 | $ 174,330 | $ 388,346 | $ 343,962
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] |  |  |  |
Net service revenues | $ 198,314 | $ 174,330 | $ 388,346 | $ 343,962
Concentration risk, percentage | 100.00% | 100.00% | 100.00% | 100.00%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member] |  |  |  |
Net service revenues | $ 103,864 | $ 88,797 | $ 202,279 | $ 173,480
Concentration risk, percentage | 52.40% | 50.90% | 52.10% | 50.40%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New Mexico [Member] |  |  |  |
Net service revenues | $ 27,907 | $ 26,473 | $ 56,381 | $ 51,912
Concentration risk, percentage | 14.10% | 15.20% | 14.50% | 15.10%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New York [Member] |  |  |  |
Net service revenues | $ 23,841 | $ 21,127 | $ 45,727 | $ 42,513
Concentration risk, percentage | 12.00% | 12.10% | 11.80% | 12.40%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | All Other States [Member] |  |  |  |
Net service revenues | $ 42,702 | $ 37,933 | $ 83,959 | $ 76,057
Concentration risk, percentage | 21.50% | 21.80% | 21.60% | 22.10%
Hospice [Member] |  |  |  |
Net service revenues | $ 50,210 | $ 52,074 | $ 99,292 | $ 99,801
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] |  |  |  |
Net service revenues | $ 50,210 | $ 52,074 | $ 99,293 | $ 99,801
Concentration risk, percentage | 100.00% | 100.00% | 100.00% | 100.00%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Ohio [Member] |  |  |  |
Net service revenues | $ 19,332 | $ 17,245 | $ 37,783 | $ 33,574
Concentration risk, percentage | 38.50% | 33.10% | 38.10% | 33.70%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member] |  |  |  |
Net service revenues | $ 11,606 | $ 13,561 | $ 23,087 | $ 16,078
Concentration risk, percentage | 23.10% | 26.00% | 23.30% | 16.10%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New Mexico [Member] |  |  |  |
Net service revenues | $ 6,540 | $ 7,846 | $ 13,026 | $ 23,102
Concentration risk, percentage | 13.00% | 15.10% | 13.10% | 23.10%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | All Other States [Member] |  |  |  |
Net service revenues | $ 12,732 | $ 13,422 | $ 25,397 | $ 27,047
Concentration risk, percentage | 25.40% | 25.80% | 25.50% | 27.10%
Home Health [Member] |  |  |  |
Net service revenues | $ 11,456 | $ 10,536 | $ 23,941 | $ 19,811
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member] |  |  |  |
Net service revenues | $ 11,456 | $ 10,536 | $ 23,941 | $ 19,811
Concentration risk, percentage | 100.00% | 100.00% | 100.00% | 100.00%
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member] |  |  |  |
Net service revenues | $ 3,363 | $ 1,466 | $ 6,732 | $ 3,232
Concentration risk, percentage | 29.40% | 13.90% | 28.10% | 16.30%
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New Mexico [Member] |  |  |  |
Net service revenues | $ 8,093 | $ 9,070 | $ 17,209 | $ 16,579
Concentration risk, percentage | 70.60% | 86.10% | 71.90% | 83.70%

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=stpr_IL
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=adus_PersonalCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=stpr_NM
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=stpr_NY
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=adus_AllOtherStatesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=adus_HospiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=stpr_OH
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=adus_HomeHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |